Cybrexa Therapeutics


Cybrexa Therapeutics is developing an entirely new class of small molecule DNA repair inhibitors that directly target the tumor microenvironment. This approach leverages a novel tumor-localizing peptide technology developed by an internationally recognized research laboratory at Yale. Our approach w... Read more

Employees

11-50

Links


Org chart

Per Hellsund
President & CEO
Collapse
Mike Needle
Chief Medical Officer
Vishwas Paralkar
Chief Scientific Officer
Victor Facchini
Director, Fp&a


Offices